Supporting Evidence

Documents with a large file size are provided in a .zip file and will need to be uncompressed after download.

Public Health and Medical Professionals for Transparency Documents Pfizer 12-15 and Moderna Court Documents

Public Health and Medical Professionals for Transparency Documents Pfizer 16+ Court Documents

Documents with a large file size are provided in a .zip file and will need to be uncompressed after download.

As of November 2023, FDA has represented that the production of the biologic product file for Comirnaty (16 years of age and older) is complete. PHMPT is

A great win for transparency that removes a stranglehold "health" authorities have had on data independent scientists need to offer solutions and address serious issues with the vaccine program.

Was it fraud? You tell me.

But first...why haven't you even heard of them?

Surgisphere, whose employees appear to include a sci-fi writer and adult content model, provided database behind Lancet and New England Journal of Medicine hydroxychloroquine studies

The Many, Many Faces of Fraud

Here are some indisputable facts about the challenge of assessing the ‘efficacy’ – in particular, benefits and risks, of Covid-19 vacci...

Three participants in the Pfizer Covid vaccine trial died shortly after vaccination and their deaths were not fully investigated, the latest trial documents released under court order reveal.

There are ways to ensure any trial will give you the results you want. Here are the top six methods used to manipulate covid research results.

The boards overseeing the COVID-19 vaccine clinical trials are supposed to be independent of pharmaceutical companies. ICAN’s intensive investigation into these boards has revealed conflicts of interest with pharmaceutical companies that are shocking to the conscience. ICAN, through its attorneys, has therefore filed a formal demand to remove these individuals from these boards.

Recoreded at San Diego Board of Supervisors Meeting 11/2/2021 Original: https://t.co/mwfvoDQUAL?amp=1 https://www.usmortality.com

From the 4/6 FDA VRBPAC Meeting

In Canada, informed consent to medical interventions - including vaccines - is the law. The Canadian Covid Care Alliance supports Informed Consent. References Contained in Video: Supreme Court of Canada Judgment - Cuthbertson vs Rasouli https://scc-csc.lexum.com/scc-csc/scc-csc/en/item/13290/index.do “The patient’s consent must be given voluntarily and must be informed.” The Ontario Health Care Consent Act https://www.ontario.ca/laws/statute/96h02 Elements of Consent CDC Risk for COVID-19 Infection, Hospitalization, and Death By Age Group https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html The New England Journal of Medicine Pfizer Vaccine Phase 2 Trial Results https://www.nejm.org/doi/full/10.1056/nejmoa2034577 FDA - Communicating Risks and Benefits https://www.fda.gov/files/about%20fda/published/Communicating-Risk-and-Benefits---An-Evidence-Based-User%27s-Guide-%28Printer-Friendly%29.pdf Consent - A Guide for Canadian Physicians (Canadian Medical Protective Association) https://www.cmpa-acpm.ca/en/advice-publications/handbooks/consent-a-guide-for-canadian-physicians "Further, even uncommon risks of great potential seriousness should be disclosed.” Reported side effects following COVID-19 vaccination in Canada (Government of Canada) https://health-infobase.canada.ca/covid-19/vaccine-safety/ Vaccine Adverse Event Reporting System https://vaers.hhs.gov British Medical Journal Sixty seconds on… Vitamin D https://www.bmj.com/content/371/bmj.m3872/rr-5 CCCA Evaluation of Ivermectin as an Effective Prophylactic, and for Treatment in Hospitalized Patients with COVID-19 https://www.canadiancovidcarealliance.org/media-resources/evaluation-of-ivermectin/ National Centre for Biotechnology Information Ivermectin, ‘Wonder drug’ from Japan: the human use perspective https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/ Pfizer Fact Sheet for Recipients and Caregivers https://www.fda.gov/media/144414/download US National Library of Medicine Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals https://clinicaltrials.gov/ct2/show/NCT04368728 Moderna Product Monograph, Including Patient Medication Information - COVID-19 Vaccine Moderna https://www.modernacovid19global.com/ca/product-monograph.pdfSupreme Court of Canada Judgment - Cuthbertson vs Rasouli https://scc-csc.lexum.com/scc-csc/scc-csc/en/item/13290/index.do “The patient’s consent must be given voluntarily and must be informed.” The Ontario Health Care Consent Act https://www.ontario.ca/laws/statute/96h02 Elements of Consent CDC Risk for COVID-19 Infection, Hospitalization, and Death By Age Group https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html The New England Journal of Medicine Pfizer Vaccine Phase 2 Trial Results https://www.nejm.org/doi/full/10.1056/nejmoa2034577 FDA - Communicating Risks and Benefits https://www.fda.gov/files/about%20fda/published/Communicating-Risk-and-Benefits---An-Evidence-Based-User%27s-Guide-%28Printer-Friendly%29.pdf Consent - A Guide for Canadian Physicians (Canadian Medical Protective Association) https://www.cmpa-acpm.ca/en/advice-publications/handbooks/consent-a-guide-for-canadian-physicians "Further, even uncommon risks of great potential seriousness should be disclosed.” Reported side effects following COVID-19 vaccination in Canada (Government of Canada) https://health-infobase.canada.ca/covid-19/vaccine-safety/ Vaccine Adverse Event Reporting System https://vaers.hhs.gov British Medical Journal Sixty seconds on… Vitamin D https://www.bmj.com/content/371/bmj.m3872/rr-5 CCCA Evaluation of Ivermectin as an Effective Prophylactic, and for Treatment in Hospitalized Patients with COVID-19 https://www.canadiancovidcarealliance.org/media-resources/evaluation-of-ivermectin/ National Centre for Biotechnology Information Ivermectin, ‘Wonder drug’ from Japan: the human use perspective https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/ Pfizer Fact Sheet for Recipients and Caregivers https://www.fda.gov/media/144414/download US National Library of Medicine Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals https://clinicaltrials.gov/ct2/show/NCT04368728 Moderna Product Monograph, Including Patient Medication Information - COVID-19 Vaccine Moderna https://www.modernacovid19global.com/ca/product-monograph.pdf

But it's actually worse than it sounds

By Maryanne Demasi, PhD

EXCLUSIVE: Freedom of Information requests reveal that the UK medical regulator, like its Australian counterpart, never inspected the Pfizer vaccine study data.

Leaked documents show that some early commercial batches of Pfizer-BioNTech’s covid-19 vaccine had lower than expected levels of intact mRNA, prompting wider questions about how to assess this novel vaccine platform, writes Serena Tinari As it conducted its analysis of the Pfizer-BioNTech covid-19 vaccine in December, the European Medicines Agency (EMA) was the victim of a cyberattack.1 More than 40 megabytes of classified information from the agency’s review were published on the dark web, and several journalists—including from The BMJ —and academics worldwide were sent copies of the leaks. They came from anonymous email accounts and most efforts to interact with the senders were unsuccessful. None of the senders revealed their identity, and the EMA says it is pursuing a criminal investigation. The BMJ has reviewed the documents, which show that regulators had major concerns over unexpectedly low quantities of intact mRNA in batches of the vaccine developed for commercial production. EMA scientists tasked with ensuring manufacturing quality—the chemistry, manufacturing, and control aspects of Pfizer’s submission to the EMA—worried about “truncated and modified mRNA species present in the finished product.” Among the many files leaked to The BMJ , an email dated 23 November by a high ranking EMA official outlined a raft of issues. In short, commercial manufacturing was not producing vaccines to the specifications expected, and regulators were unsure of the implications. EMA responded by filing two “major objections” with Pfizer, along with a host of other questions it wanted addressed. The email identified “a significant difference in % RNA integrity/truncated species” between the clinical batches and proposed commercial batches—from around 78% to 55%. The root cause was unknown and the impact of this loss of RNA integrity on safety and efficacy of the vaccine was “yet to be defined,” the email said. Ultimately, on 21 December, …

(Washington, DC) – Judicial Watch announced today that it obtained 314 pages of records from the Centers for Disease Control and Prevention that show Director Rochelle Walensky’s communications, which include her request for details about the death of a teenager who died days after receiving a coronavirus vaccination. Judicial Watch obtained the records in response to a Freedom […]

(Washington, DC) – Judicial Watch announced today that it received 249 pages of records from the Department of Health and Human Services (HHS) detailing the extensive media plans for a propaganda campaign to push the COVID-19 vaccine.The records were received in in response to an August 2021 Freedom of Information Act (FOIA)lawsuit filed after HHS failed to respond to a April 19, 2021 request for records related to the Biden HHS’ “COVID-19 Community Corps” program (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:22-cv-02315)).

(Washington, DC) – Judicial Watch announced today that it received 1,081 pages of records from the U.S. Department of Health and Human Services (HHS) detailing internal discussions about myocarditis and the COVID vaccine. Other documents detail adverse “events for which a contributory effect of the vaccine could not be excluded.”

(Washington, DC) – Judicial Watch announced today it filed a Freedom of Information Act (FOIA) lawsuit against the U.S. Department of Health and Human Services (HHS) for records on COVID-19 vaccine safety studies (Judicial Watch, Inc. v. U.S. Department of Health and Human Services (No. 1:22-cv-03153)).The lawsuit was filed in the U.S. District Court for the District of Columbia after National Institutes of Allergies and Infectious Diseases (a component of HHS) inadequately responded to a June 1, 2022, Judicial Watch FOIA request for:

(Washington, DC) – Judicial Watch announced today it received 43 pages of heavily redacted records from the Food and Drug Administration (FDA) regarding the COVID-19 booster vaccine.

Johnson & Johnson relied on studies showing that vaccine DNA particles and injected virus particles were still present in test animals months after injection(Washington, DC) – Judicial Watch announced today that it received 466 pages of records from the Department of Health and Human Services (HHS) regarding biodistribution studies and related data for the COVID-19 vaccines that show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals, eight to 48 hours after injection.

Judicial Watch announced today that it filed a Freedom of Information Act (FOIA) lawsuit against the U.S. Department of Defense for records and communications relating to the data contained in the Defense Medical Epidemiology Database (Judicial Watch, Inc. v. U.S. Department of Defense (No. 1:22-cv-03043)).The Armed Forces Health Surveillance Branch’s Defense Medical Epidemiology Database is a web-based tool designed to provide access to:

(Washington, DC) – Judicial Watch announced today it received 57 pages of heavily redacted records from the U.S. Department of Health and Human Services (HHS) that show, just two days prior to FDA approval of the Pfizer-BioNTech COVID-19 vaccine, a discussion between U.S. and UK health regulators regarding the COVID shot and “anaphylaxis” with the regulators emphasizing their “mutual confidentiality agreement.”